Get started
Author

Jose L. Gallardo

OpenAlex ID: A5031553608
Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux
2010 · Sagar Agarwal, Ramola Sane, et al. · Journal of Pharmacology and Experimental Therapeutics · 255
PDF
De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA
2009 · Stephen M. Wiesner, Stacy A. Decker, et al. · Cancer Research · 171
PDF
Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents
2012 · Sagar Agarwal, Rajendar K. Mittapalli, et al. · Molecular Cancer Therapeutics · 93
9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant glioma
2012 · Aaron M. Teitelbaum, Jose L. Gallardo, et al. · Cancer Chemotherapy and Pharmacology · 15
Data from Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents
2023 · Sagar Agarwal, Rajendar K. Mittapalli, et al.
Data from Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents
2023 · Sagar Agarwal, Rajendar K. Mittapalli, et al.
Supplementary Table 1 from Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents
2023 · Sagar Agarwal, Rajendar K. Mittapalli, et al.
PDF
Supplementary Table 1 from Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents
2023 · Sagar Agarwal, Rajendar K. Mittapalli, et al.
Supplementary Figures 1-4 from De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA
2023 · Stephen M. Wiesner, Stacy A. Decker, et al.
PDF
Supplementary Figures 1-4 from De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA
2023 · Stephen M. Wiesner, Stacy A. Decker, et al.
Data from De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA
2023 · Stephen M. Wiesner, Stacy A. Decker, et al.
Data from De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA
2023 · Stephen M. Wiesner, Stacy A. Decker, et al.
Works count: 12
Citation count: 534
H-index: 4
I10-index: 4
Year
Topic
Type